The report projects a significant increase in dementia cases across Europe by 2050, with estimated numbers rising to 14.3 million in the EU27 and 19.9 million in EU and non-EU countries combined. Alzheimer Europe urges decision-makers to prioritize dementia research, healthcare infrastructure, and support for families and carers.
ACCESS-AD aims to address Alzheimer's disease challenges with a coordinated framework for diagnosis, treatment and monitoring. The project combines advanced neuroimaging with digital biomarkers to support early patient identification and personalized treatment pathways.
The ATN dataset is a multi-cohort study that includes harmonised clinical and biomarker data from over 350 participants across ten European research cohorts. This dataset provides valuable insights into shared disease mechanisms among Alzheimer's disease, Parkinson's disease, and Dementia with Lewy Bodies.
The International Working Group proposes a new approach to diagnosing Alzheimer's disease, focusing on clinical evaluation supported by biomarkers. This distinction is crucial for identifying those who have the disease and those at risk, paving the way for targeted research and personalized treatments.
The European Platform for Neurodegenerative Diseases has launched its Cohort Catalogue, featuring an extensive list of international cohorts across the neurodegeneration disease spectrum. Researchers can search and filter cohorts by metadata characteristics to discover relevant studies and initiate new collaborations.
People with dementia have twice the risk for developing COVID-19, with high hospitalization rates and mortality. Alzheimer Europe urges governments to prioritize these groups in vaccination campaigns to prevent further harm.
The report reviews recent changes in EU research policy, identifies key barriers and enablers for data sharing, and maps the Horizon 2020 dementia research portfolio. Key findings include a need to overcome technical, financial and motivational obstacles to data sharing, as well as involving people with dementia in research design.
The number of people with dementia from minority ethnic groups is increasing in Europe, but uptake of services remains low. Alzheimer Europe has launched a guide to support health and social care workers in providing intercultural dementia care.
Alzheimer Europe's new report highlights the need to prioritize dementia research and policy in the EU. The organization recommends allocating fair resources to existing programs, prioritizing dementia within chronic diseases policies, and recognizing it as a disability.
The number of people with dementia in Europe is estimated to almost double by 2050, from 7.9 million to 14.3 million, according to a new report by Alzheimer Europe. The prevalence of dementia has decreased in recent years, but this trend is expected to reverse unless better treatments and prevention strategies are developed.